Bariatric Surgery and the Risk of New-Onset Atrial Fibrillation in Swedish Obese Subjects

Journal of the American College of Cardiology

Volumn 68, Issue 23, 2016, Pages 2497-2504

  Jamaly, Shabbar ^a   Carlsson, Lena ^b   Peltonen, Markku ^c   Jacobson, Peter ^b   Sjöström, Lars ^b   Karason, Kristjan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

atrial fibrillation; bariatric surgery; obesity; weight loss

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; ATRIAL FIBRILLATION; BARIATRIC SURGERY; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; OBESITY; ONSET AGE; OUTCOME ASSESSMENT; POPULATION RISK; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK REDUCTION; SEX DIFFERENCE; SOCIAL PSYCHOLOGY; SWEDEN; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO; WEIGHT REDUCTION; CLINICAL TRIAL; COMPLICATION; FORECASTING; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RISK ASSESSMENT; RISK FACTOR;

ATRIAL FIBRILLATION; BARIATRIC SURGERY; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SWEDEN;

EID: 85002643928     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.09.940     Document Type: Article

References (32)

1. 1 Ng, M., Fleming, T., Robinson, M., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384 (2014), 766–781.
2. 2 Lavie, C.J., Milani, R.V., Ventura, H.O., Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53 (2009), 1925–1932.
3. 3 Lip, G.Y., Tse, H.F., Lane, D.A., Atrial fibrillation. Lancet 379 (2012), 648–661.
4. 4 Camm, A.J., Kirchhof, P., Lip, G.Y., et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31 (2010), 2369–2429.
5. 5 Heeringa, J., van der Kuip, D.A., Hofman, A., et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27 (2006), 949–953.
6. 6 Lloyd-Jones, D.M., Wang, T.J., Leip, E.P., et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110 (2004), 1042–1046.
7. 7 Wanahita, N., Messerli, F.H., Bangalore, S., Gami, A.S., Somers, V.K., Steinberg, J.S., Atrial fibrillation and obesity: results of a meta-analysis. Am Heart J 155 (2008), 310–315.
8. 8 DeMaria, E.J., Bariatric surgery for morbid obesity. N Engl J Med 356 (2007), 2176–2183.
9. 9 Sjostrom, L., Review of the key results from the Swedish Obese Subjects (SOS) trial: a prospective controlled intervention study of bariatric surgery. J Intern Med 273 (2013), 219–234.
10. 10 Sjostrom, L., Peltonen, M., Jacobson, P., et al. Bariatric surgery and long-term cardiovascular events. JAMA 307 (2012), 56–65.
11. 11 Sjostrom, L., Narbro, K., Sjostrom, C.D., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 (2007), 741–752.
12. 12 Sjostrom, L., Larsson, B., Backman, L., et al. Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord 16 (1992), 465–479.
13. 13 Grunstein, R.R., Stenlof, K., Hedner, J.A., Peltonen, M., Karason, K., Sjöström, L., Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity. Sleep 30 (2007), 703–710.
14. 14 Smith, J.G., Platonov, P.G., Hedblad, B., Engstrom, G., Melander, O., Atrial fibrillation in the Malmo Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 25 (2010), 95–102.
15. 15 Ludvigsson, J.F., Andersson, E., Ekbom, A., et al. External review and validation of the Swedish national inpatient register. BMC Public Health, 11, 2011, 450.
16. 16 Wing, R.R., Bolin, P., Brancati, F.L., et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369 (2013), 145–154.
17. 17 Alonso, A., Bahnson, J.L., Gaussoin, S.A., et al. Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial. Am Heart J 170 (2015), 770–777.
18. 18 Sjostrom, L., Lindroos, A.K., Peltonen, M., et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351 (2004), 2683–2693.
19. 19 Abed, H.S., Wittert, G.A., Leong, D.P., et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA 310 (2013), 2050–2060.
20. 20 Pathak, R.K., Middeldorp, M.E., Meredith, M., et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol 65 (2015), 2159–2169.
21. 21 Healey, J.S., Connolly, S.J., Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. Am J Cardiol 91 (2003), 9G–14G.
22. 22 Russo, C., Jin, Z., Homma, S., et al. Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol 57 (2011), 1368–1374.
23. 23 Wang, T.J., Parise, H., Levy, D., et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292 (2004), 2471–2477.
24. 24 Zethelius, B., Gudbjornsdottir, S., Eliasson, B., Eeg-Olofsson, K., Svensson, A.M., Cederholm, J., Risk factors for atrial fibrillation in type 2 diabetes: report from the Swedish National Diabetes Register (NDR). Diabetologia 58 (2015), 2259–2268.
25. 25 Gami, A.S., Pressman, G., Caples, S.M., et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 110 (2004), 364–367.
26. 26 Aviles, R.J., Martin, D.O., Apperson-Hansen, C., et al. Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003), 3006–3010.
27. 27 Kardassis, D., Bech-Hanssen, O., Schonander, M., Sjöström, L., Karason, K., The influence of body composition, fat distribution, and sustained weight loss on left ventricular mass and geometry in obesity. Obesity (Silver Spring) 20 (2012), 605–611.
28. 28 Kardassis, D., Grote, L., Sjostrom, L., Hedner, J., Karason, K., Sleep apnea modifies the long-term impact of surgically induced weight loss on cardiac function and inflammation. Obesity (Silver Spring) 21 (2013), 698–704.
29. 29 Karason, K., Molgaard, H., Wikstrand, J., Sjostrom, L., Heart rate variability in obesity and the effect of weight loss. Am J Cardiol 83 (1999), 1242–1247.
30. 30 Schnabel, R.B., Yin, X., Gona, P., et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 386 (2015), 154–162.
31. 31 Neter, J.E., Stam, B.E., Kok, F.J., Grobbee, D.E., Geleijnse, J.M., Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 42 (2003), 878–884.
32. 32 Nalliah, C.J., Sanders, P., Kottkamp, H., Kalman, J.M., The role of obesity in atrial fibrillation. Eur Heart J 37 (2015), 1565–1572.